Vantedge Medical Executive Chair and CEO Brian King [Photo courtesy of Vantedge Medical]
The company followed up the announcement one day later by naming Brigham Brandon as chief operating officer.
“I have had the honor to work with Brigham for the better part of the last two decades and in three different companies,” King said in a news release announcing the hire. “He is, simply put, one of the best operations professionals in the medical device space. Fully embracing servant leadership, he approaches solutions with a patient-first mindset while promoting a quality-focused culture.”
King was previously CEO of Viant Medical, leading what Vantedge described as “a complete transformation of a focused, niche $220 million organization into a leading $1 billion global services provider to the medical industry with 24 locations and more than 6,000 employees.”
Before Viant, King’s career included more than a decade at Covidien, ultimately serving as group president of emerging markets. Vantedge said King’s division was responsible for nearly 60% of Covidien’s growth and generated more than $2 billion of sales with more than 4,500 employees.
And before he joined the medtech industry, King flew aircraft-carrier-based combat jets for the U.S. Navy.
Brandon, for his part, led operations for Viant Medical’s Advanced Metals Solutions business, and before that spent more than a decade at Covidien.
King “possesses a demonstrated track record of success with some of the most admired companies in the healthcare industry as well as a powerful and unique set of leadership experiences,” Aterian co-founder and partner Brandon Bethea said in a news release announcing King’s new role as CEO. “Vantedge could not be more fortunate to have Brian add CEO to his existing responsibilities as Chairman. Having worked closely with Brian in the last two years, I am certain that Brian’s relentless focus on world class product quality, organizational excellence and servant leadership will benefit not just Vantedge, but our customers and supply chain partners as well.”
San Jose, California-based Vantedge’s subsidiaries include TMK Manufacturing, JL Haley, Swiss Precision Machining and Omni Components. Vantedge is a portfolio company of Aterian Investment Partners, which combined the brands under the Vantedge name in November.
“As I look to the future of Vantedge, I am both excited and humbled to have this opportunity to take on the additional role as CEO and to work alongside our dedicated employees,” King said in the release. “Together, we will execute our vision — to be the premier metals-based MedTech solutions partner from concept to full-scale manufacturing. We have an amazing team of professionals coupled with the most comprehensive suite of unique and necessary process capabilities in the medical technology space. Our mission is strong and intentionally aligns with those of our valued medical OEM customers because, as partners, we can truly make a difference in the lives of patients and their families.”
Vantedge Medical offers metals-based medtech solutions from concept to full-scale manufacturing, specializing in the development and manufacturing for robotic surgery, orthopedics, surgical instruments, dental and more.
Related: The most important medtech leadership changes of 2023
This story was originally published on Jan. 11, 2024, and updated Jan. 12 with news of Brigham Brandon’s hiring.
